Experian (EXPN.L): 1Q27 North America and UK performance drive optimism

Research evidence excerpt

Experian (EXPN.L): 1Q27 North America and UK performance drive optimism

Action |

17 Jul 2026 18:05:12 ET │ 17 pages

Experian (EXPN.L)

1Q27 North America and UK performance drive optimism

CITI'S TAKE

Per Experian (EXPN.L) - Upgrade to Buy on AI-Driven Productivity and

Mortgage Opportunities, we are buyers of Experian because we believe that

AI-driven productivity can deliver attractive margin progression in North Buy

America. Our FY27E and FY27E adj. EBIT of $2,695m (previously $2,694m) Price (17 Jul 26 16:30) £27.19

and $3,007m are c.1% and c.3% above BBG consensus. North America 7%

in 1Q27 suggests that strong productivity in FY27E is likely. The key debate Target price £38.12↓

on the stock recently has related to whether AI will result in Experian’s from £38.24

customers relying less on its services. 1Q27 organic growth of 5% in UK and Expected share price return 40.2%Ireland (from 3% in 2H26 and 1% in 1H26) – despite no material macro

improvement – suggests that EXPN is taking share and that the value of its Expected dividend yield 2.3%

products to its customers is increasing. Our TP goes from £38.24 to £38.12 Expected total return 42.5%

due to the USD having weakened. Market Cap £24,147M

US$31,954MUK organic growth acceleration suggests increasing customer demand for EXPN’s

products in the UK – we view this as positive given the AI debate: Experian’s

organic growth in the UK accelerated from 3% in 2H26 to 5% in 1Q27, with B2B

organic growth rising to 5% from 1% in 4Q26. This is despite UK monthly GDP growth

estimates continuing to run at c.1% and weak consumer confidence. Management Price Performance

stated that this growth was supported by new business wins, with revenue from the (RIC: EXPN.L, BB: EXPN LN)

Ascend platform increasing.